Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
2011 ◽
Vol 23
(1)
◽
pp. 43-50
◽
2020 ◽
Vol 3
(4)
◽
pp. 464-473
◽
2017 ◽
Vol 5
(7)
◽
2020 ◽
Vol 85
(1)
◽
pp. 137-143
◽